Nature

Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation

Allogeneic hematopoietic cell transplantation (alloHCT) is the intensive but optimal therapy for higher risk acute types of leukemia (AML, ALL, CML in accelerated phase (AP) or blast crisis (BC)) and ...
Nature

Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time

Autologous hematopoietic cell transplantation (AHCT) continues to be an integral component of initial treatment strategy in eligible patients with multiple myeloma ...
ascopubs.org

Clinical significance of time to relapse and the distinction between breast cancer recurrences and new primary tumors.

The SUCCESS-C trial: Interim analysis of toxicity evaluating the role of an anthracycline-free chemotherapy regimen in the adjuvant treatment of HER2/neu-negative breast cancer. Cosmetic outcome 1, 2, ...
Medical Xpress

A math model may predict time to relapse after prostate cancer surgery

A mathematical model that uses four consecutive prostate-specific antigen (PSA) test results from a patient who had prostate cancer surgery can predict the time it might take for the disease to ...